Systematic Characterization of Prognostic Values of Peroxiredoxin Family in Gastric Cancer

Table 3

Association between PRDX expression and OS in GC patients with different HER2 expression status.

PRDXs	HER2 status	Cases	Low	High	HR (95% CI)	value
PRDX1	Negative	532	266	266	0.62 (0.49–0.77)	<0.001
	Positive	344	172	172	0.75 (0.58–0.98)	0.031
PRDX2	Negative	532	266	266	0.66 (0.52–0.82)	<0.001
	Positive	344	172	172	0.56 (0.43–0.73)	<0.001
PRDX3	Negative	532	266	266	0.51 (0.40–0.64)	<0.001
	Positive	344	172	172	0.97 (0.75–1.25)	0.809
PRDX4	Negative	532	266	266	0.63 (0.51–0.79)	<0.001
	Positive	344	172	172	0.72 (0.56–0.94)	0.014
PRDX5	Negative	429	214	215	0.89 (0.68–1.16)	0.390
	Positive	202	101	101	0.77 (0.53–1.12)	0.171
PRDX6	Negative	532	266	266	0.81 (0.65–1.01)	0.061
	Positive	344	172	172	1.05 (0.81–1.35)	0.737